相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - A systematic review and meta-analysis
Maaike C. Gerards et al.
ATHEROSCLEROSIS (2015)
Inhibition of PCSK9 Transcription by Berberine Involves Down-regulation of Hepatic HNF1 α Protein Expression through the Ubiquitin-Proteasome Degradation Pathway
Bin Dong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Critical Role of mRNA Destabilizing Protein Heterogeneous Nuclear Ribonucleoprotein D in 3′ Untranslated Region-Mediated Decay of Low-Density Lipoprotein Receptor mRNA in Liver Tissue
Amar Bahadur Singh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
An assessment by the Statin Intolerance Panel: 2014 update
John R. Guyton et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial
Rosa Sola et al.
PLOS ONE (2014)
Clinical response to statins: Mechanism(s) of variable activity and adverse effects
Cesare R. Sirtori et al.
ANNALS OF MEDICINE (2012)
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
Livia Pisciotta et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome
I-Te Lee et al.
NUTRITION RESEARCH (2012)
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome
Flora Affuso et al.
WORLD JOURNAL OF CARDIOLOGY (2012)
Functional Analysis of LDLR Promoter and 5′ UTR Mutations in Subjects with Clinical Diagnosis of Familial Hypercholesterolemia
Isabel De Castro-Oros et al.
HUMAN MUTATION (2011)
Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet
Bruno Trimarco et al.
MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM (2011)
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia
Raffaele Izzo et al.
JOURNAL OF HYPERTENSION (2010)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Berberine decreases PCSK9 expression in HepG2 cells
Jamie Cameron et al.
ATHEROSCLEROSIS (2008)
Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase
Dev K. Singh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Statins and myotoxicity: a therapeutic limitation
Atul Tiwari et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts
R Menendez et al.
ARCHIVES OF MEDICAL RESEARCH (2001)
分享论文
